Close
More
 
 

Join Now

It's Free - Always

First name
 
Last name
 
Zip Code
 
Country of Practice
 
 
 
Specialty
Email
 
Password
 
Confirm password
 
Terms
I have read and agree to the Participant Terms and Conditions
 
 
 

is already registered on QuantiaMD

Is this you? Enter your password to continue.
The password you entered is incorrect. Please try again or choose a different option.
Create new password? Click here and instructions on creating a new password will be sent to the above email address.
Need more help? Contact Member Support
 
 

is already registered on QuantiaMD

 
 
Instructions to create a new password have been sent to the following email address:

For further assistance, please Contact Member Support
Thanks for Registering.

Create new password?

Please enter your email address below, and we will send you a link to create a new password.

Submit

Create new password?

Email address:
 
Password
 
Confirm password
 
Submit
Dr. Carol H. Wysham, Clinical Associate Professor of Medicine at the University of Washington School of Medicine, presents the 2-Part Series "Evidence in Practice: The Unique Role of GLP-1 Receptor Agonists in the Management of Type 2 Diabetes." Earn .5 AMA PRA Category 1 Credit for each presentation and join the expert-led discussion on top cases submitted by your peers. Brought to you through a partnership of CMEcorner.com and QuantiaMD.
Presented By:
Carol H. Wysham, MD, FACP, FACE
Carol H. Wysham, MD, FACP, FACE
Clinical Associate Professor of Medicine
University of Washington School of Medicine
Section Head, Rockwood Center for Diabetes and Endocrinology
Rockwood Clinic
Spokane, WA
Carol Wysham, MD, FACP, FACE
26 votes
9 Comments
Last activity:
Earlier this month
Carol Wysham, MD, FACP, FACE
28 votes
10 Comments
Last activity:
Earlier this month
Carol Wysham, MD, FACP, FACE
23 votes
8 Comments
Last activity:
Earlier this month
 
Terms | Privacy | FAQ | support@quantiamd.com | 1-800-773-4162
Copyright © 2017 Aptus Health, Inc. All rights reserved.
 
Version 2.13.137.97